Navigation Links
ECC Signs a Contract for the Finance, Design, and Construction of a Premier Cancer Institute in Ibadan, Nigeria
Date:7/24/2014

BURLINGAME, Calif., July 24, 2014 /PRNewswire/ -- ECC West Africa, LLC (ECC) signed a contract in Denver, Colorado with University College Hospital (UCH) Ibadan Board of Management for the first phase of a development project to finance, design, construct, and operate and maintain a new, state-of-the-art Cancer Institute in Ibadan, Nigeria. Under the first of the 4-phase project, ECC will conduct feasibility studies and prepare scoping documents and funding applications. UCH Ibadan intends to finance and develop the Cancer Institute using funding from Export-Import Bank and other financial institutions.

The Cancer Institute will be an innovative, holistic diagnostic center, including oncological screening, diagnosis, treatment, prevention, training, and research.

"Medical infrastructure and accessibility are critical steps in leading the fight against disease throughout Africa," comments ECC's President & CEO, Manjiv S. Vohra, PE, DBIA.  "UCH Ibadan and its new Cancer Institute will provide premier oncological services, touching the lives of millions of people and their families affected by cancer. We are proud to lead the development of this ground-breaking institution."

Professor Temitope Oluwagbenga Alonge, MBBS Ibadan, MD Leicester, FRCS Edinburgh, FWACS, UCH Ibadan Chief Medical Director, represented the Board of Management during the signing. He stated, "Cancer is a leading cause of death at UCH Ibadan. Accurate diagnosis of cancer is germane to targeted treatment modalities. Our partnership with ECC, a world-class, renowned, and reputable company, will no doubt ensure a more accurate diagnosis, and by extension, appropriate and targeted treatment of cancers, as well as offer opportunities for cutting-edge research and the development of protocols in UCH, Nigeria, and the West African sub-region."

ECC teamed with strategic partners General Electric Healthcare and Health Technologies International to develop the Cancer Institute. Additionally, a major component of the project involves building capacity of the local workforce. "ECC invests heavily in building relationships with local Nigerian partners who will play a pivotal role in the development of the Cancer Institute," stated Mr. Vohra.

The UCH Ibadan Cancer Institute is estimated to be completed within 2 years.

About UCH Ibadan: Established by an act of parliament in November 1952, UCH Ibadan is the leading teaching hospital and tertiary healthcare provider in Nigeria. UCH Ibadan provides excellent healthcare training, cutting-edge research, and unparalleled healthcare services to Nigerians and citizens of neighboring West African States. Its Accident and Emergency Department averages 6,000 new patients annually, and its clinics serve 150,000 new patients each year. uch-ibadan.org.ng

About ECC: Established in 1985, ECC is an employee-owned company that provides a complete range of services to support its clients' missions, including design-build, construction, environmental remediation, energy, munitions response, and international development. ECC serves the U.S. Agency for International Development; U.S. Departments of Defense, Energy, and State; and other international agencies.  www.ecc.net


'/>"/>
SOURCE ECC
Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. Bacterin Signs Distribution Agreement with Jeil for LeForte Craniomaxillofacial System
2. Roche Signs Agreement with PTC Therapeutics to Advance Treatment for Spinal Muscular Atrophy (SMA)
3. BioRestorative Therapies Signs Material Manufacturing Agreement With University of Utah
4. The European Union Signs Grant Contract to Fund a 2 Million Euro Biotechnology Research Project Led by Hadassah College Jerusalem
5. Metamark Genetics Signs Collaboration Agreement on Novel Therapeutic Targets with Janssen Biotech
6. Agendia Signs Contract with Blue Shield of California
7. New England Biolabs Signs Agreement with Synthetic Genomics Inc. to Launch Gibson Assembly™ Master Mix for Molecular and Synthetic Biology Applications
8. Volition Signs Collaboration Agreement With Abcodia
9. MiMedx Signs Agreement with Systagenix for Global Distribution of EpiFix®
10. Psyche Systems Corporation Signs Strategic Alliance with Siemens Healthcare to Provide Anatomic Pathology Solutions
11. IntelliCell BioSciences Signs Technology Licensing Agreement with Stem Cells 21 Thailand
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)...  Matchbook, Inc., a company specializing in procurement ... announced today the appointment of Jim Shuman ... nearly 25 years of experience in supply chain, ... two decades in executive level roles as the ... and, most recently headed global logistics and procurement ...
(Date:2/10/2016)... , ... February 10, 2016 , ... ... the International Society of Pharmaceutical Engineering (ISPE) Rocky Mountain Chapter 21st Annual Vendor ... expecting to fill more than 100 tables for its annual event, which will ...
(Date:2/10/2016)... ... February 10, 2016 , ... SonaCare ... training and support program, Sonalink™ remote monitoring. The inaugural launch of this new ... February 5th, connecting Dr. Samuel Peretsman to a HIFU technical expert at SonaCare ...
(Date:2/10/2016)... ... February 10, 2016 , ... Curoverse announced ... On Azure, Arvados provides capabilities for managing and processing genomic and health data ... from major institutions collecting and analyzing genomic data,” said Adam Berrey chief executive ...
Breaking Biology Technology:
(Date:2/3/2016)... , February 4, 2016 --> ... SEK 1,351.5 M (105.0), up 1,187% compared with fourth quarter of 2014. ... to SEK 517.6 M (loss: 30.0). Earnings per share increased ... was SEK 537.4 M (neg: 74.7). , ... Revenues amounted to SEK 2,900.5 M (233.6), up 1,142% compared with 2014. ...
(Date:2/3/2016)... , Feb. 3, 2016 Vigilant Solutions announces ... Department in Missouri solved two ... reader (LPR) data from Vigilant Solutions. Brian ... in which the victim was walking out of a convenience store and witnessed ... next to his vehicle, striking his vehicle and leaving ...
(Date:2/2/2016)... Feb. 2, 2016  BioMEMS devices deployed ... focused on medical screening and diagnostic applications, ... Wearable devices that facilitate and assure continuous ... movement are being bolstered through new opportunities ... signal acquisition coupled with wireless connectivity and ...
Breaking Biology News(10 mins):